“…For example, if binding of IP 3 to the IP 3 -receptor is blocked by injecting the IP 3 antagonist heparin, or a functionally inhibitory IP 3 -receptor antibody, Ca 2+ release at fertilisation and egg activation is also blocked (Miyazaki et al, 1993). Furthermore, there appears to be an increased turnover of phosphoinositide lipids and increase in IP 3 levels in sea urchin and frog eggs at fertilisation (Nuccitelli, 1991;Ciapa et al, 1992;Snow et al, 1996;Lee and Shen, 1998) and Ca 2+ release at egg activation can be inhibited in both species with the PLC inhibitor U73122 (Dupont et al, 1996;Lee and Shen, 1998). However, we must not dismiss nor neglect the possible involvement of other naturally-occurring calcium releasing agents and their respective signalling pathways; cyclic ADP-ribose (cADPR), nicotinic acid adenine dinucleotide phosphate (NAADP), nitric oxide (NO), and cyclic GMP (cGMP) pathways all play crucial roles in Ca 2+ release in various physiological signalling mechanisms (Lee, 1977;Galione et al, 2000;Bootman et al, 2001;Leckie et al, 2003).…”